Structure Therapeutics American Stock Alpha and Beta Analysis
| GPCR Stock | 35.88 0.19 0.53% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Structure Therapeutics American. It also helps investors analyze the systematic and unsystematic risks associated with investing in Structure Therapeutics over a specified time horizon. Remember, high Structure Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Structure Therapeutics' market risk premium analysis include:
Beta (0.38) | Alpha (0.39) | Risk 3.83 | Sharpe Ratio (0.08) | Expected Return (0.31) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Structure |
Structure Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Structure Therapeutics market risk premium is the additional return an investor will receive from holding Structure Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Structure Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Structure Therapeutics' performance over market.| α | -0.39 | β | -0.38 |
Structure Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Structure Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Structure Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Structure Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By understating and applying Structure Therapeutics stock market price indicators, traders can identify Structure Therapeutics position entry and exit signals to maximize returns.
Structure Therapeutics Return and Market Media
The median price of Structure Therapeutics for the period between Fri, Feb 16, 2024 and Thu, May 16, 2024 is 39.52 with a coefficient of variation of 8.6. The daily time series for the period is distributed with a sample standard deviation of 3.43, arithmetic mean of 39.93, and mean deviation of 2.72. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights | 03/08/2024 |
2 | Former CFO sues Peninsula drug company, alleges domestic violence incident led to her firing | 03/13/2024 |
3 | Disposition of 21997 shares by Fmr Llc of Structure Therapeutics subject to Rule 16b-3 | 03/14/2024 |
4 | GPCR Stock Earnings Structure Therapeutics Beats EPS for Q4 2023 | 03/15/2024 |
5 | GPCR Therapeutics Announces Publication in PNAS Using Cutting Edge Spectroscopy to Detect GPCR Heteromers on Live Cancer Cells | 04/01/2024 |
6 | Structure Therapeutics Now Covered by Analysts at Cantor Fitzgerald - Defense World | 04/10/2024 |
7 | Insider Trading | 04/17/2024 |
8 | BMO maintains 83 target on Structure Therapeutics shares | 04/23/2024 |
About Structure Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Structure or other stocks. Alpha measures the amount that position in Structure Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 12.62 | 7.16 | 19.14 | 10.31 | Net Debt To EBITDA | 2.78 | 1.72 | 1.22 | 1.85 |
Structure Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Structure Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Structure Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Structure Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Structure Therapeutics. Please utilize our Beneish M Score to check the likelihood of Structure Therapeutics' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Structure Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Structure Therapeutics Backtesting, Structure Therapeutics Valuation, Structure Therapeutics Correlation, Structure Therapeutics Hype Analysis, Structure Therapeutics Volatility, Structure Therapeutics History and analyze Structure Therapeutics Performance. Note that the Structure Therapeutics information on this page should be used as a complementary analysis to other Structure Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Structure Stock analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Structure Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.